Multi Drug Resistant Tuberculosis (MDR- TB)
Medical Review
Overview of Multi Drug Resistant Tuberculosis (MDR- TB)
Multidrug Resistant Tuberculosis (MDR-TB) refers to tuberculosis that does not respond to at least isoniazid and rifampicin, the 2 most potent anti-TB drugs. Tuberculosis is a bacterial infection mainly affecting the lungs which is caused by Mycobacterium tuberculosis.
Signs and Symptoms of Multi Drug Resistant Tuberculosis (MDR- TB)
Persistent cough, Hemoptysis, Weight loss, Fever, Loss of appetite, Night sweats, Chest pain, Difficulty breathing
Common Causes of Multi Drug Resistant Tuberculosis (MDR- TB)
Not completing the full course of treatment, Defaulting follow ups, Incorrect consumption of medications, Poor quality of medication, Incorrect treatment given by doctors
Risk Factors of Multi Drug Resistant Tuberculosis (MDR- TB)
Older age group, People living far from health facilities, Poverty, Immunocompromised people, People living in overcrowded areas, Underlying respiratory diseases
Investigation Techniques for Multi Drug Resistant Tuberculosis (MDR- TB)
Full blood count, Chest X-ray, Tuberculin skin test, Acid fast bacilli (AFB) test, Sputum culture and sensitivity, Nucleic acid amplification test (NAAT)
Treatment and Prevention of Multi Drug Resistant Tuberculosis (MDR- TB)
Other anti-TB medications, Fluoroquinolone, Wear face masks at all times, Stay away from overcrowded areas, Strictly follow the treatment course, BCG vaccination for newborns and infants
Available Multi Drug Resistant Tuberculosis (MDR- TB) Medicines
No medicines currently available for this condition.



